Biogen Inc
Here’s why Biogen’s promising Alzheimer’s drug data is also good news for Eli Lilly
We don’t own Eli Lilly exclusively for its potential Alzheimer’s treatment. However, we still find Biogen’s topline data to be very encouraging for Lilly. Source
Read More
Shares earning the biggest moves midday: Apple, Netflix, Biogen, Canopy Advancement and more
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Check out the firms earning headlines in midday buying and selling. Apple — Apple shares fell 3.4% on Wednesday pursuing a report that the organization is ditching ideas to increase new Iphone creation. As an alternative of aiming to enhance output by 6 million models […]
Read More
2 takeaways from our daily meeting: What’s behind the bounce and Club stocks in the news
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Market gets an oversold bounce Quick Club mentions: AAPL, LLY, EL 1. Market gets an oversold bounce U.S. stocks recovered after falling earlier Wednesday. Treasury yields pulled back from their highs and […]
Read More
Shares earning the greatest moves premarket: Biogen, Thor Industries, Lyft and much more
In this report LYFT AAPL OCGN THO DIS BIIB Comply with your favourite stocksMake Free of charge ACCOUNT look at now Online video1:4301:43 Information Update – Pre-Marketplaces Information Briefing Examine out the firms earning headlines before the bell: Biogen (BIIB) – Biogen soared 45.6% in premarket trading just after Biogen and Japanese associate Eisai mentioned […]
Read More
Biogen to pay $900 million to settle allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen will pay $900 million to settle a lawsuit that alleged the company gave doctors kickbacks to encourage them prescribe its drugs, the Justice Department announced on Monday. A former Biogen employee turned whistleblower, Michael Bawduniak, sued the pharmaceutical company in 2012 on behalf of […]
Read More
This large cap fund is staying above water in this bear market by being the ‘antithesis of ARK’
James Abate expects that his fund distinguished itself this year by maintaining a traditional bottom-up perspective on stocks. The fund manager has maintained a stellar track record through his Centre American Select Equity Fund (DHAMX) , which he started in 2011, that is in the top 1% of funds in its large-cap blend cohort over […]
Read More
3 takeaways from the Investing Club’s ‘Morning Meeting’ on Wednesday
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Stocks are up – for now We’re fans of Starbucks incoming CEO Quick mentions: LLY, MRVL, BHC 1. Stocks are up – for now Wall Street recovered Wednesday after earlier […]
Read More
4 takeaways from the Investing Club’s ‘Morning Meeting’ on Tuesday
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments: Oscillator says market still oversold Our trades on DVN and CRM Quick mentions: HON and LLY Watching these bullpen stocks 1. Oscillator says market still oversold Stocks were in the […]
Read More
Stocks making the biggest moves midday: Netflix, Las Vegas Sands, Bath & Body Works and more
The Netflix logo is seen on their office in Hollywood, California. Lucy Nicholson | Reuters Check out the companies making headlines in midday trading. Netflix — Shares of the streaming company popped 7.4% a day after Netflix posted a smaller-than-expected subscriber loss in the recent quarter. Netflix reported a beat on earnings but a miss […]
Read More
Stocks making the biggest moves premarket: Baker Hughes, Biogen, Netflix and more
Check out the companies making headlines before the bell: Baker Hughes (BKR) – The oilfield services company reported second-quarter adjusted earnings of 11 cents per share, just half of what analysts had forecast. Revenue also fell below estimates, with Baker Hughes citing various challenges including component shortages and supply chain inflation. Baker Hughes tumbled 6% […]
Read More